Nanocurcumin: A New Approach for Cancer Treatment
Author Information
Author(s): Bisht Savita, Feldmann Georg, Soni Sheetal, Ravi Rajani, Karikar Collins, Maitra Amarnath, Maitra Anirban
Primary Institution: Johns Hopkins University School of Medicine
Hypothesis
Can nanoparticle-encapsulated curcumin improve the bioavailability and therapeutic efficacy of curcumin in cancer therapy?
Conclusion
Nanocurcumin enhances the clinical potential of curcumin by allowing it to be easily dispersed in water and maintaining its anti-cancer properties.
Supporting Evidence
- Nanocurcumin was synthesized using cross-linked polymeric nanoparticles.
- It showed comparable therapeutic efficacy to free curcumin against pancreatic cancer cell lines.
- Nanocurcumin was able to induce apoptosis and inhibit NFκB activation in cancer cells.
- The encapsulation efficiency of curcumin in the nanoparticles was over 90%.
- Nanocurcumin was non-toxic to normal cells in vitro and in vivo.
Takeaway
Nanocurcumin is a special form of curcumin that can dissolve in water better, making it easier to use for treating cancer.
Methodology
The study involved synthesizing polymeric nanoparticles to encapsulate curcumin and testing their efficacy against pancreatic cancer cell lines.
Limitations
The study primarily focused on in vitro models, and further in vivo studies are needed to confirm the findings.
Participant Demographics
The study involved human pancreatic cancer cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website